Link: https://links.sgx.com/1.0.0/corporate-announcements/RD1ZH20HL91D6SNP/dc5152b9a4b4ba6b2bb30294c632b5e0a21d04f775af8971542648b85c4935d7

Summary:

• Hyphens Pharma International Limited has successfully completed the second tranche (Tranche 2) of the acquisition of Ardence Pharma Sdn Bhd.
• The completion of Tranche 2 involved the acquisition of an additional 17% of the issued and paid-up ordinary share capital in Ardence Pharma.
• Following this completion, the Group's total shareholding in Ardence Pharma has increased to 82%.
• The consideration paid for the Tranche 2 shares amounted to RM10,887,718.79, which is approximately S$3.35 million.
• With an 82% shareholding, Ardence Pharma is now a majority-owned entity of Hyphens Pharma International Limited.